Global Corneal Transplant Market

Corneal Transplant Market Size, Share, Growth Analysis, By Indications(Fungal corneal ulcer, Bullous keratopathy), By Type(Penetrating keratoplasty, Endothelial keratoplasty), By End-user(Hospitals, Eye clinics) - Industry Forecast 2024-2031


Report ID: SQMIG35A2814 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 96 | Figures: 66

Corneal Transplant Market Regional Insights

North America is poised to dominate, driven by growing awareness of eye donation programs in the region and active participation by several institutions in the US. The market in North America has gained a significant market share, making it in the industry Underlined to be highly significant. At the same time, the corneal implant market in Canada has shown the fastest growth in this segment.

Asia-Pacific Corneal Implants Market is expected to witness the fastest compound annual growth rate (CAGR) from 2024 to 2031, driven by the rise in eye diseases due to lifestyle changes in the region diabetes, obesity, malnutrition, other lifestyle factors such as diseases are associated with increasing incidence of vision loss, increasing the demand for corneal transplant options Notably, China has highlighted its significant contribution to the region by gaining a significant market share in the corneal transplant market.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is poised to grow from USD 489.99 million in 2023 to USD 873.88 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

The competitive environment of the Corneal Transplant market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'Florida Lions Eye Bank', 'Alcon Inc.', 'Aurolab', 'CorneaGen', 'AJL Ophthalmic S.A.', 'DIOPTEX', 'Massachusetts Eye and Ear', 'San Diego Eye Bank', 'KeraMed, Inc.', 'Presbia PLC'

A major factor driving the growth of the corneal transplant market is the significant increase in the prevalence of cataracts. Conditions including keratoconus, Fuchs dystrophy, keratitis, cataracts, cataracts, and cataracts, require corneal transplantation as a necessary medical intervention. Notably is that data from the Eye Research Foundation in the US. There exhibit a large load, each being 100,000, About 50 to 200 individuals struggle with complex corneal disease keratoconus. This prevalence highlights the growing demand for corneal implants, as these devices play an important role in eye diseases.

The phenomenal growth observed in the corneal transplant market can be attributed to several key factors that combine to increase the demand for these advanced products. The most common late-onset form is Fuchs endothelial dysplasia, a condition that commonly affects individuals over the age of 40. It says, according to an article published in March 2020 in the journal Progress in Retina and Eye Research.

North America is poised to dominate, driven by growing awareness of eye donation programs in the region and active participation by several institutions in the US. The market in North America has gained a significant market share, making it in the industry Underlined to be highly significant. At the same time, the corneal implant market in Canada has shown the fastest growth in this segment.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Corneal Transplant Market

Product ID: SQMIG35A2814

$5,300
BUY NOW GET FREE SAMPLE